latest news releases from the newsroom
Neutral Tandem's Wren, Gavillet, and Junkroski Named Ernst & Young Entrepreneur Of The Year 2007 Award Winners in Lake Michigan Area Program
CHICAGO, June 28, 2007 (PRIME NEWSWIRE) -- Neutral Tandem, the nation's leading independent provider of tandem services for inter-carrier traffic, today announced that Rian Wren, CEO, Ron Gavillet, Executive V.P. and General Counsel, and Rob Junkroski, CFO, received the Ernst & Young Entrepreneur Of The Year(r) 2007 Award in the Technology category in the Lake Michigan Area program. According to Ernst & Young, the award recognizes outstanding entrepreneurs who are building and leading dynamic, growing businesses. An independent panel of judges selected Mr. Wren, Mr. Gavillet and Mr. Junkroski and the award was presented at an Ernst & Young Entrepreneur Of The Year gala event at Navy Pier, Chicago on June 22, 2007.
JetBlue Airways Corporation
JetBlue Expands in the Empire State: Announcing Nonstop Service Between Syracuse and Fort Lauderdale
SYRACUSE, N.Y., June 28, 2007 (PRIME NEWSWIRE) -- JetBlue Airways (Nasdaq:JBLU) today continues to expand options for customers in the Empire State with the addition of new nonstop service between Syracuse and Fort Lauderdale, effective November 1. The award-winning airline will operate one daily flight on the route year-round, providing Syracuse with its only nonstop link to South Florida. Fares start as low as $99(a) each way, and include the airline's signature 36 channels of DIRECTV(r) programming and more than 100 channels of XM Satellite Radio.
TapImmune Inc. Announces Acquisition of Core TAP Technologies and Intellectual Property From The University of British Columbia
VANCOUVER, British Columbia, June 28, 2007 (PRIME NEWSWIRE) -- TapImmune Inc. (OTCBB:TPIM), a biotechnology company specializing in the development of immunotherapeutics for cancer and vaccines for infectious diseases, announced today that it has fulfilled its financial obligation to The University of British Columbia for the proposed acquisition of its key Transporter Associated with Antigen Processing (TAP) technology platform and patents. All financial terms with The University of British Columbia have been met. Technology assignment and transfer is expected to be completed in the next week.